Subgroups | No. of studies | No. of subjects | OR | 95% CI | Q | I2(%) | P§ |
---|---|---|---|---|---|---|---|
Depression | Â | Â | Â | Â | Â | Â | Â |
Control group | Â | Â | Â | Â | Â | Â | 0.013 |
   Disease control | 13 | 2554 | 6.03 | 4.23-8.61 | 37.63*** | 65.5 |  |
   Normal control | 8 | 1286 | 13.58 | 6.26-29.46 | 34.56*** | 79.7 |  |
Method of depression assessment | Â | Â | Â | Â | Â | 0.094 | |
   Clinical diagnosis | 5 | 1010 | 12.41 | 5.16-29.84 | 23.33*** | 78.6 |  |
Self-report questionnaire | 12 | 2474 | 6.83 | 4.70-9.93 | 52.23*** | 71.3 | Â |
Cancer type | Â | Â | Â | Â | Â | Â | - |
   Breast cancer | 3 | 380 | 10.84 | 1.44-81.85 | 14.83*** | 86.5 |  |
   Liver cancer | 3 | 794 | 4.54 | 2.92-7.05 | 5.20 | 42.3 |  |
   Lung cancer | 2 | 400 | 4.20 | 2.57-6.88 | 0.34 | 0 |  |
Anxiety | Â | Â | Â | Â | Â | Â | Â |
Control group | Â | Â | Â | Â | Â | Â | 0.000 |
   Disease control | 11 | 2154 | 4.40 | 3.05-6.36 | 28.62** | 61.6 |  |
   Normal control | 6 | 786 | 15.47 | 10.00-23.95 | 2.44 | 0 |  |
Method of anxiety assessment | Â | Â | Â | Â | Â | 0.013 | |
   Clinical diagnosis | 4 | 650 | 8.42 | 4.83-14.70 | 6.31 | 36.6 |  |
Self-report questionnaire | 10 | 1974 | 5.83 | 3.64-9.34 | 48.78*** | 75.4 | Â |
Cancer type | Â | Â | Â | Â | Â | Â | - |
   Breast cancer | 3 | 390 | 8.24 | 3.49-19.44 | 4.22 | 52.6 |  |
   Liver cancer | 2 | 394 | 2.95 | 1.87-4.63 | 0.87 | 0 |  |